The University of California San Francisco (UCSF) Health Awards named CardioWise, Inc. as a Rising Star in the Clinical Diagnostic Tool category. The awards highlight the health tech industry, showcasing the best new products and technologies in digital health and life sciences. These technologies will define the future of healthcare and are supported by the nation’s top healthcare accelerators, venture capitalists, and academic leaders.
100+ judges vetted over 1,250 company submissions across 11 categories.
As described by the Health Hub: “The goal of the UCSF Digital Health Awards is to ultimately help patients access amazing innovations by recognizing and awarding the great companies with the best in-market digital products and services."
CardioWise™ is commercializing patented, non-invasive Cardiac CT analysis software that produces a quantified 4D image model of the human heart, called Stretch Quantifier for Endocardial Engraved Zones™ (SQuEEZ™). CardioWise heart analysis software combined with cardiac CT is a single diagnostic test that is able to provide quantitative analysis of the myocardium, arteries and valves with an unprecedented level of detail. It has the opportunity to become the new gold standard of care for heart health analysis. CardioWise is a VIC Technology Venture Development portfolio company.